Literature DB >> 7766599

Solution structure of the Ras-binding domain of c-Raf-1 and identification of its Ras interaction surface.

S D Emerson1, V S Madison, R E Palermo, D S Waugh, J E Scheffler, K L Tsao, S E Kiefer, S P Liu, D C Fry.   

Abstract

The structure of the Ras-binding domain of human c-Raf-1 (residues 55-132) has been determined in solution by nuclear magnetic resonance (NMR) spectroscopy. Following complete assignment of the backbone and side-chain 1H, 15N, and 13C resonances, the structure was calculated using the program CHARMM. Over 1300 NOE-derived constraints were applied, resulting in a detailed structure. The fold of Raf55-132 consists of a five-stranded beta-sheet, a 12-residue alpha-helix, and an additional one-turn helix. It is similar to those of ubiquitin and the IgG-binding domain of protein G, although the three proteins share very little sequence identity. The surface of Raf55-132 that interacts with Ras has been identified by monitoring perturbation of line widths and chemical shifts of 15N-labeled Raf55-132 resonances during titration with unlabeled Ras-GMPPNP. The Ras-binding site is contained within a spatially contiguous patch comprised of the N-terminal beta-hairpin and the C-terminal end of the alpha-helix.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766599     DOI: 10.1021/bi00021a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  The three-dimensional solution structure of the SRC homology domain-2 of the growth factor receptor-bound protein-2.

Authors:  M M Senior; A F Frederick; S Black; N J Murgolo; L M Perkins; O Wilson; M E Snow; Y S Wang
Journal:  J Biomol NMR       Date:  1998-02       Impact factor: 2.835

3.  Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21.

Authors:  J Ma; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 4.  Targeting protein-protein interactions for cancer therapy.

Authors:  David C Fry; Lyubomir T Vassilev
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

5.  Massive sequence perturbation of a small protein.

Authors:  F-X Campbell-Valois; K Tarassov; S W Michnick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

6.  A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy.

Authors:  J B Pracyk; K Tanaka; D D Hegland; K S Kim; R Sethi; I I Rovira; D R Blazina; L Lee; J T Bruder; I Kovesdi; P J Goldshmidt-Clermont; K Irani; T Finkel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Role of the J-domain in the cooperation of Hsp40 with Hsp70.

Authors:  M K Greene; K Maskos; S J Landry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction.

Authors:  S Donald Emerson; Robert Palermo; Chao-Min Liu; Jefferson W Tilley; Li Chen; Waleed Danho; Vincent S Madison; David N Greeley; Grace Ju; David C Fry
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

9.  Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIA.

Authors:  M P Foster; D S Wuttke; K R Clemens; W Jahnke; I Radhakrishnan; L Tennant; M Reymond; J Chung; P E Wright
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

10.  Improved binding of raf to Ras.GDP is correlated with biological activity.

Authors:  Christina Kiel; Daniel Filchtinski; Michael Spoerner; Gideon Schreiber; Hans Robert Kalbitzer; Christian Herrmann
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.